Logo image of PRLB

PROTO LABS INC (PRLB) Stock Fundamental Analysis

USA - NYSE:PRLB - US7437131094 - Common Stock

54.19 USD
+0.43 (+0.8%)
Last: 10/21/2025, 8:04:00 PM
54.19 USD
0 (0%)
After Hours: 10/21/2025, 8:04:00 PM
Fundamental Rating

4

Taking everything into account, PRLB scores 4 out of 10 in our fundamental rating. PRLB was compared to 130 industry peers in the Machinery industry. No worries on liquidiy or solvency for PRLB as it has an excellent financial health rating, but there are worries on the profitability. PRLB has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year PRLB was profitable.
PRLB had a positive operating cash flow in the past year.
Of the past 5 years PRLB 4 years were profitable.
PRLB had a positive operating cash flow in each of the past 5 years.
PRLB Yearly Net Income VS EBIT VS OCF VS FCFPRLB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M

1.2 Ratios

Looking at the Return On Assets, with a value of 1.99%, PRLB is doing worse than 60.00% of the companies in the same industry.
The Return On Equity of PRLB (2.23%) is worse than 63.85% of its industry peers.
With a Return On Invested Capital value of 2.11%, PRLB is not doing good in the industry: 67.69% of the companies in the same industry are doing better.
The Average Return On Invested Capital over the past 3 years for PRLB is significantly below the industry average of 10.01%.
Industry RankSector Rank
ROA 1.99%
ROE 2.23%
ROIC 2.11%
ROA(3y)-2.81%
ROA(5y)0.4%
ROE(3y)-3.29%
ROE(5y)0.41%
ROIC(3y)2.43%
ROIC(5y)3.16%
PRLB Yearly ROA, ROE, ROICPRLB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

Looking at the Profit Margin, with a value of 2.91%, PRLB is in line with its industry, outperforming 40.77% of the companies in the same industry.
PRLB's Profit Margin has declined in the last couple of years.
PRLB's Operating Margin of 4.38% is on the low side compared to the rest of the industry. PRLB is outperformed by 63.85% of its industry peers.
PRLB's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 44.17%, PRLB belongs to the top of the industry, outperforming 81.54% of the companies in the same industry.
In the last couple of years the Gross Margin of PRLB has declined.
Industry RankSector Rank
OM 4.38%
PM (TTM) 2.91%
GM 44.17%
OM growth 3Y-14.89%
OM growth 5Y-21.81%
PM growth 3Y-21.48%
PM growth 5Y-24.92%
GM growth 3Y-0.78%
GM growth 5Y-2.78%
PRLB Yearly Profit, Operating, Gross MarginsPRLB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

9

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so PRLB is destroying value.
PRLB has less shares outstanding than it did 1 year ago.
The number of shares outstanding for PRLB has been reduced compared to 5 years ago.
PRLB has a better debt/assets ratio than last year.
PRLB Yearly Shares OutstandingPRLB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
PRLB Yearly Total Debt VS Total AssetsPRLB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

An Altman-Z score of 11.35 indicates that PRLB is not in any danger for bankruptcy at the moment.
PRLB has a Altman-Z score of 11.35. This is amongst the best in the industry. PRLB outperforms 93.08% of its industry peers.
PRLB has a debt to FCF ratio of 0.01. This is a very positive value and a sign of high solvency as it would only need 0.01 years to pay back of all of its debts.
PRLB's Debt to FCF ratio of 0.01 is amongst the best of the industry. PRLB outperforms 94.62% of its industry peers.
PRLB has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
PRLB has a better Debt to Equity ratio (0.00) than 89.23% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Altman-Z 11.35
ROIC/WACC0.22
WACC9.42%
PRLB Yearly LT Debt VS Equity VS FCFPRLB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.3 Liquidity

PRLB has a Current Ratio of 3.31. This indicates that PRLB is financially healthy and has no problem in meeting its short term obligations.
PRLB's Current ratio of 3.31 is amongst the best of the industry. PRLB outperforms 80.77% of its industry peers.
A Quick Ratio of 3.09 indicates that PRLB has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 3.09, PRLB belongs to the best of the industry, outperforming 90.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.31
Quick Ratio 3.09
PRLB Yearly Current Assets VS Current LiabilitesPRLB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

3

3. Growth

3.1 Past

PRLB shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -9.14%.
The earnings per share for PRLB have been decreasing by -10.19% on average. This is quite bad
Looking at the last year, PRLB shows a decrease in Revenue. The Revenue has decreased by -0.12% in the last year.
The Revenue has been growing slightly by 1.78% on average over the past years.
EPS 1Y (TTM)-9.14%
EPS 3Y1.69%
EPS 5Y-10.19%
EPS Q2Q%7.89%
Revenue 1Y (TTM)-0.12%
Revenue growth 3Y0.87%
Revenue growth 5Y1.78%
Sales Q2Q%7.51%

3.2 Future

Based on estimates for the next years, PRLB will show a small growth in Earnings Per Share. The EPS will grow by 0.06% on average per year.
Based on estimates for the next years, PRLB will show a small growth in Revenue. The Revenue will grow by 4.88% on average per year.
EPS Next Y-7.89%
EPS Next 2Y0.06%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.01%
Revenue Next 2Y4.88%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
PRLB Yearly Revenue VS EstimatesPRLB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M 500M
PRLB Yearly EPS VS EstimatesPRLB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3

1

4. Valuation

4.1 Price/Earnings Ratio

PRLB is valuated quite expensively with a Price/Earnings ratio of 34.08.
62.31% of the companies in the same industry are cheaper than PRLB, based on the Price/Earnings ratio.
PRLB's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 27.77.
The Price/Forward Earnings ratio is 33.20, which means the current valuation is very expensive for PRLB.
Compared to the rest of the industry, the Price/Forward Earnings ratio of PRLB indicates a slightly more expensive valuation: PRLB is more expensive than 66.92% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of PRLB to the average of the S&P500 Index (23.23), we can say PRLB is valued slightly more expensively.
Industry RankSector Rank
PE 34.08
Fwd PE 33.2
PRLB Price Earnings VS Forward Price EarningsPRLB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

PRLB's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. PRLB is more expensive than 61.54% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of PRLB indicates a somewhat cheap valuation: PRLB is cheaper than 68.46% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 19.63
EV/EBITDA 20.57
PRLB Per share dataPRLB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.06%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for PRLB!.
Industry RankSector Rank
Dividend Yield N/A

PROTO LABS INC

NYSE:PRLB (10/21/2025, 8:04:00 PM)

After market: 54.19 0 (0%)

54.19

+0.43 (+0.8%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)07-31 2025-07-31/bmo
Earnings (Next)10-31 2025-10-31/bmo
Inst Owners92.16%
Inst Owner Change-0.83%
Ins Owners1.06%
Ins Owner Change1.82%
Market Cap1.29B
Analysts78.18
Price Target51 (-5.89%)
Short Float %2.92%
Short Ratio3.76
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.34%
Min EPS beat(2)10.87%
Max EPS beat(2)17.81%
EPS beat(4)4
Avg EPS beat(4)22.12%
Min EPS beat(4)10.87%
Max EPS beat(4)43.37%
EPS beat(8)8
Avg EPS beat(8)29.73%
EPS beat(12)11
Avg EPS beat(12)24.46%
EPS beat(16)14
Avg EPS beat(16)22.81%
Revenue beat(2)2
Avg Revenue beat(2)1.71%
Min Revenue beat(2)0.02%
Max Revenue beat(2)3.41%
Revenue beat(4)3
Avg Revenue beat(4)1.07%
Min Revenue beat(4)-0.63%
Max Revenue beat(4)3.41%
Revenue beat(8)5
Avg Revenue beat(8)0.83%
Revenue beat(12)7
Avg Revenue beat(12)0.53%
Revenue beat(16)8
Avg Revenue beat(16)0.22%
PT rev (1m)0%
PT rev (3m)11.11%
EPS NQ rev (1m)0%
EPS NQ rev (3m)5.66%
EPS NY rev (1m)1.24%
EPS NY rev (3m)7.52%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)3.23%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.48%
Valuation
Industry RankSector Rank
PE 34.08
Fwd PE 33.2
P/S 2.54
P/FCF 19.63
P/OCF 18.22
P/B 1.95
P/tB 3.49
EV/EBITDA 20.57
EPS(TTM)1.59
EY2.93%
EPS(NY)1.63
Fwd EY3.01%
FCF(TTM)2.76
FCFY5.09%
OCF(TTM)2.97
OCFY5.49%
SpS21.31
BVpS27.85
TBVpS15.51
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.99%
ROE 2.23%
ROCE 3.27%
ROIC 2.11%
ROICexc 2.48%
ROICexgc 5.07%
OM 4.38%
PM (TTM) 2.91%
GM 44.17%
FCFM 12.96%
ROA(3y)-2.81%
ROA(5y)0.4%
ROE(3y)-3.29%
ROE(5y)0.41%
ROIC(3y)2.43%
ROIC(5y)3.16%
ROICexc(3y)2.8%
ROICexc(5y)3.78%
ROICexgc(3y)5.45%
ROICexgc(5y)6.71%
ROCE(3y)3.77%
ROCE(5y)4.91%
ROICexcg growth 3Y-8.13%
ROICexcg growth 5Y-18.97%
ROICexc growth 3Y-4.98%
ROICexc growth 5Y-24.03%
OM growth 3Y-14.89%
OM growth 5Y-21.81%
PM growth 3Y-21.48%
PM growth 5Y-24.92%
GM growth 3Y-0.78%
GM growth 5Y-2.78%
F-Score6
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Debt/EBITDA 0
Cap/Depr 14.62%
Cap/Sales 1.01%
Interest Coverage 250
Cash Conversion 123.98%
Profit Quality 444.91%
Current Ratio 3.31
Quick Ratio 3.09
Altman-Z 11.35
F-Score6
WACC9.42%
ROIC/WACC0.22
Cap/Depr(3y)51.87%
Cap/Depr(5y)76.84%
Cap/Sales(3y)3.95%
Cap/Sales(5y)5.94%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-9.14%
EPS 3Y1.69%
EPS 5Y-10.19%
EPS Q2Q%7.89%
EPS Next Y-7.89%
EPS Next 2Y0.06%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.12%
Revenue growth 3Y0.87%
Revenue growth 5Y1.78%
Sales Q2Q%7.51%
Revenue Next Year5.01%
Revenue Next 2Y4.88%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-29.61%
EBIT growth 3Y-14.15%
EBIT growth 5Y-20.42%
EBIT Next Year58.27%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y62.71%
FCF growth 3Y48.42%
FCF growth 5Y4.96%
OCF growth 1Y12.72%
OCF growth 3Y12.13%
OCF growth 5Y-7.69%